These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 28755476)

  • 41. Systematic profiling of SH3-mediated Tau-Partner interaction network in Alzheimer's disease by integrating in silico analysis and in vitro assay.
    Wang X; Chang C; Wang D; Hong S
    J Mol Graph Model; 2019 Jul; 90():265-272. PubMed ID: 31112821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cells Control BIN1-Mediated Membrane Tubulation by Altering the Membrane Charge.
    Gowrisankaran S; Wang Z; Morgan DG; Milosevic I; Mim C
    J Mol Biol; 2020 Feb; 432(4):1235-1250. PubMed ID: 31857086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emerin self-assembly mechanism: role of the LEM domain.
    Samson C; Celli F; Hendriks K; Zinke M; Essawy N; Herrada I; Arteni AA; Theillet FX; Alpha-Bazin B; Armengaud J; Coirault C; Lange A; Zinn-Justin S
    FEBS J; 2017 Jan; 284(2):338-352. PubMed ID: 27960036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural Basis for Auto-Inhibition of the NDR1 Kinase Domain by an Atypically Long Activation Segment.
    Xiong S; Lorenzen K; Couzens AL; Templeton CM; Rajendran D; Mao DYL; Juang YC; Chiovitti D; Kurinov I; Guettler S; Gingras AC; Sicheri F
    Structure; 2018 Aug; 26(8):1101-1115.e6. PubMed ID: 29983373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy.
    Sibille N; Sillen A; Leroy A; Wieruszeski JM; Mulloy B; Landrieu I; Lippens G
    Biochemistry; 2006 Oct; 45(41):12560-72. PubMed ID: 17029411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Domain-specific incorporation of noninvasive optical probes into recombinant proteins.
    Muralidharan V; Cho J; Trester-Zedlitz M; Kowalik L; Chait BT; Raleigh DP; Muir TW
    J Am Chem Soc; 2004 Nov; 126(43):14004-12. PubMed ID: 15506763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The ESCRT-III pathway facilitates cardiomyocyte release of cBIN1-containing microparticles.
    Xu B; Fu Y; Liu Y; Agvanian S; Wirka RC; Baum R; Zhou K; Shaw RM; Hong T
    PLoS Biol; 2017 Aug; 15(8):e2002354. PubMed ID: 28806752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
    Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC
    Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The 14-3-3/SLP76 protein-protein interaction in T-cell receptor signalling: a structural and biophysical characterization.
    Soini L; Leysen S; Davis J; Westwood M; Ottmann C
    FEBS Lett; 2021 Feb; 595(3):404-414. PubMed ID: 33159816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones.
    Sun FH; Zhao P; Zhang N; Kong LL; Wong CCL; Yun CH
    Nat Commun; 2021 Feb; 12(1):1028. PubMed ID: 33589610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding modes of Bcl-2 homology 3 (BH3) peptides with anti-apoptotic protein A1 and redesign of peptide inhibitors: a computational study.
    Chen Y; Wang J; Zhang J; Wang W
    J Biomol Struct Dyn; 2018 Nov; 36(15):3967-3977. PubMed ID: 29137527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of water molecules in the binding of class I and II peptides to the SH3 domain of the Fyn tyrosine kinase.
    Camara-Artigas A; Ortiz-Salmeron E; Andujar-Sánchez M; Bacarizo J; Martin-Garcia JM
    Acta Crystallogr F Struct Biol Commun; 2016 Sep; 72(Pt 9):707-12. PubMed ID: 27599862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recognition of lysine-rich peptide ligands by murine cortactin SH3 domain: CD, ITC, and NMR studies.
    Rubini C; Ruzza P; Spaller MR; Siligardi G; Hussain R; Udugamasooriya DG; Bellanda M; Mammi S; Borgogno A; Calderan A; Cesaro L; Brunati AM; Donella-Deana A
    Biopolymers; 2010; 94(3):298-306. PubMed ID: 19921743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR.
    Ippel H; Miller MC; Vértesy S; Zheng Y; Cañada FJ; Suylen D; Umemoto K; Romanò C; Hackeng T; Tai G; Leffler H; Kopitz J; André S; Kübler D; Jiménez-Barbero J; Oscarson S; Gabius HJ; Mayo KH
    Glycobiology; 2016 Aug; 26(8):888-903. PubMed ID: 26911284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology.
    Chapuis J; Hansmannel F; Gistelinck M; Mounier A; Van Cauwenberghe C; Kolen KV; Geller F; Sottejeau Y; Harold D; Dourlen P; Grenier-Boley B; Kamatani Y; Delepine B; Demiautte F; Zelenika D; Zommer N; Hamdane M; Bellenguez C; Dartigues JF; Hauw JJ; Letronne F; Ayral AM; Sleegers K; Schellens A; Broeck LV; Engelborghs S; De Deyn PP; Vandenberghe R; O'Donovan M; Owen M; Epelbaum J; Mercken M; Karran E; Bantscheff M; Drewes G; Joberty G; Campion D; Octave JN; Berr C; Lathrop M; Callaerts P; Mann D; Williams J; Buée L; Dewachter I; Van Broeckhoven C; Amouyel P; Moechars D; Dermaut B; Lambert JC;
    Mol Psychiatry; 2013 Nov; 18(11):1225-34. PubMed ID: 23399914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. β-catenin regulates FOXP2 transcriptional activity via multiple binding sites.
    Richter G; Gui T; Bourgeois B; Koyani CN; Ulz P; Heitzer E; von Lewinski D; Burgering BMT; Malle E; Madl T
    FEBS J; 2021 May; 288(10):3261-3284. PubMed ID: 33284517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural Basis for MARK1 Kinase Autoinhibition by Its KA1 Domain.
    Emptage RP; Lemmon MA; Ferguson KM; Marmorstein R
    Structure; 2018 Aug; 26(8):1137-1143.e3. PubMed ID: 30099988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular basis for CPAP-tubulin interaction in controlling centriolar and ciliary length.
    Zheng X; Ramani A; Soni K; Gottardo M; Zheng S; Ming Gooi L; Li W; Feng S; Mariappan A; Wason A; Widlund P; Pozniakovsky A; Poser I; Deng H; Ou G; Riparbelli M; Giuliano C; Hyman AA; Sattler M; Gopalakrishnan J; Li H
    Nat Commun; 2016 Jun; 7():11874. PubMed ID: 27306797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transient structure and SH3 interaction sites in an intrinsically disordered fragment of the hepatitis C virus protein NS5A.
    Feuerstein S; Solyom Z; Aladag A; Favier A; Schwarten M; Hoffmann S; Willbold D; Brutscher B
    J Mol Biol; 2012 Jul; 420(4-5):310-23. PubMed ID: 22543239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.